Prestige Consumer Healthcare (PBH) Other financing activities (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Other financing activities came in at $752000.0 in Q3 2025, down 53.49% year-on-year from $1.6 million in Q3 2024, and down 76.16% quarter-over-quarter from $3.2 million in Q2 2025.
Prestige Consumer Healthcare (PBH) Other financing activities (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other financing activities history runs 16 years deep, the most recent figure standing at $752000.0 for Q3 2025.
- On a quarterly basis, Other financing activities fell 53.49% year-over-year to $752000.0 in Q3 2025; TTM through Dec 2025 was $18.7 million, a 4.6% decrease from a year earlier, with the FY2025 full-year figure at $14.8 million, down 18.17% from the prior year.
- Other financing activities retreated to $752000.0 in Q3 2025 per PBH's latest filing, from $3.2 million in the prior quarter.
- Across five years, Other financing activities topped out at $14.8 million in Q1 2025 and bottomed at $199000.0 in Q1 2023.
- The 5-year median for Other financing activities is $2.1 million (2023), against an average of $3.6 million.
- Across the five-year window, Other financing activities soared 7620.51% in 2021 and slumped 74.26% in 2022, its largest moves.
- Year by year, Other financing activities stood at $3.0 million in 2021, then surged by 88.77% to $5.7 million in 2022, then tumbled by 71.24% to $1.6 million in 2023, then surged by 435.05% to $8.7 million in 2024, then plunged by 91.4% to $752000.0 in 2025.
- Per Business Quant, the three latest PBH Other financing activities figures stand at $752000.0 (Q3 2025), $3.2 million (Q2 2025), and $14.8 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 752,000.00 |
| Sep 30, 2025 | 752,000.00 |
| Jun 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 3.16 Mn |
| Mar 31, 2025 | 14.80 Mn |
| Mar 31, 2025 | 14.80 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 7.27 Mn |
| Mar 31, 2024 | 7.27 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 7.03 Mn |
| Jun 30, 2023 | 7.03 Mn |